Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
M01AH01	REVCOX	G	Celecoxib - 200mg	200mg	Capsule	506,629 L.L
M01AH01	REVCOX	G	Celecoxib - 200mg	200mg	Capsule	506,629 L.L
N05AH04	REZAL XR	G	Quetiapine fumarate - 200mg	200mg	Tablet, extended release	2,116,552 L.L
B01AF01	RIBAVAN	G	Rivaroxaban - 20mg	20mg	Tablet, film coated	1,343,843 L.L
B01AF01	RIXALTA 20	G	Rivaroxaban - 20mg	20mg	Tablet, film coated	1,164,664 L.L
A02BC01	RISEK	G	Omeprazole - 20mg	20mg	Capsule, enteric coated	302,365 L.L
G04BE08	RAVANA	G	Tadalafil - 20mg	20mg	Tablet	500,421 L.L
M01AC02	REUTENOX	G	Tenoxicam - 20mg	20mg	Tablet, coated	576,508 L.L
A02BC02	RAZON 20	G	Pantoprazole (sodium) - 20mg	20mg	Tablet, enteric coated	747,176 L.L
A02BC04	RABEC	G	Rabeprazole (sodium) - 20mg	20mg	Tablet, film coated	212,327 L.L
A02BC04	RABEZOL 20	G	Rabeprazole sodium - 20mg	20mg	Tablet, enteric coated	282,847 L.L
A02BC04	RABEZOL 20	G	Rabeprazole sodium - 20mg	20mg	Tablet, enteric coated	639,925 L.L
A02BC04	RAMEP	G	Rabeprazole (sodium) - 20mg	20mg	Tablet, gastroresistant	518,809 L.L
A02BC04	RAZOLE 20	G	Rabeprazole sodium - 20mg	20mg	Tablet, enteric coated	282,847 L.L
A02BC04	RAZOLE 20	G	Rabeprazole sodium - 20mg	20mg	Tablet, enteric coated	639,925 L.L
C10AA07	ROSUCOR	G	Rosuvastatin (calcium) - 20mg	20mg	Tablet, film coated	487,623 L.L
C10AA07	ROSUPHAR	G	Rosuvastatin (calcium) - 20mg	20mg	Tablet, film coated	487,623 L.L
C10AA07	ROSUVAS	G	Rosuvastatin (calcium) - 20mg	20mg	Tablet, film coated	450,187 L.L
C10AA07	ROVASTIN	G	Rosuvastatin (calcium) - 20mg	20mg	Tablet	812,705 L.L
C10AA07	ROXARDIO	G	Rosuvastatin (calcium) - 20mg	20mg	Tablet, film coated	749,058 L.L
C05CX	REPARIL	B	Aescine - 20mg	20mg	Tablet, sugar coated	510,660 L.L
C09AA02	RENITEC	B	Enalapril maleate - 20mg	20mg	Tablet	405,840 L.L
L03AX16	REVIXIL 20	G	Plerixafor - 20mg/ml	20mg/ml	Injectable solution	248,280,900 L.L
J01DB05	ROXIL	G	Cefadroxil (monohydrate) - 250mg/5ml	250mg/5ml	Powder for suspension	459,594 L.L
B02BX05	REVOLADE	B	Eltrombopag Olamine - 25mg	25mg	Tablet, film coated	75,701,015 L.L
L01EX10	RYDAPT	B	Midostaurin - 25mg	25mg	Capsule, soft	1,214,817,915 L.L
L01EX10	RYDAPT	B	Midostaurin - 25mg	25mg	Capsule, soft	607,408,958 L.L
B03XA06	REBLOZYL	BioTech	Luspatarcept - 25mg	25mg	Injectable powder for solution	125,960,784 L.L
L04AX04	REVLIMID	B	Lenalidomide - 25mg	25mg	Capsule	127,865,045 L.L
N03AE01	RIVOTRIL	B	Clonazepam - 2mg	2mg	Tablet, scored	503,941 L.L